Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Osteoporosis

  Free Subscription


Articles published in J Bone Miner Res

Retrieve available abstracts of 205 articles:
HTML format



Single Articles


    June 2022
  1. KORHONEN MT, Kujala UM, Kettunen J, Korhonen OV, et al
    Longitudinal associations of high-volume and vigorous-intensity exercise with hip fracture risk in men.
    J Bone Miner Res. 2022 Jun 14. doi: 10.1002/jbmr.4624.
    PubMed     Abstract available


  2. GURUSAMY P, Larsen BA, Allen RT, Ward SR, et al
    Density and Fat Fraction of the Psoas, Paraspinal, and Oblique Muscle Groups are Associated with Lumbar Vertebral Bone Mineral Density in a Multi-Ethnic Community-Living Population: The Multi-Ethnic Study of Atherosclerosis.
    J Bone Miner Res. 2022 Jun 12. doi: 10.1002/jbmr.4634.
    PubMed     Abstract available


  3. TAI TW, Hwang JS, Li CC, Hsu JC, et al
    The impact of various anti-osteoporosis drugs on all-cause mortality after hip fractures: A nationwide population study.
    J Bone Miner Res. 2022 Jun 11. doi: 10.1002/jbmr.4627.
    PubMed     Abstract available


  4. LU T, Forgetta V, Greenwood CMT, Richards JB, et al
    Identifying Causes of Fracture Beyond Bone Mineral Density: Evidence from Human Genetics.
    J Bone Miner Res. 2022 Jun 11. doi: 10.1002/jbmr.4632.
    PubMed     Abstract available


  5. DAHL C, Madsen C, Omsland TK, Sogaard AJ, et al
    The Association of Cold Ambient Temperature with Fracture Risk and Mortality: National data from Norway - A NOREPOS* Study.
    J Bone Miner Res. 2022 Jun 11. doi: 10.1002/jbmr.4628.
    PubMed     Abstract available


  6. SU Y, Yeung SSY, Chen YM, Leung JCS, et al
    The Associations of Dietary Inflammatory Potential With Musculoskeletal Health in Chinese Community-Dwelling Older People: The Mr. OS and Ms. OS (Hong Kong) Cohort Study.
    J Bone Miner Res. 2022;37:1179-1187.
    PubMed     Abstract available


    May 2022
  7. LEBLANC ES, Hovey KM, Cauley JA, Stefanick M, et al
    Cumulative Endogenous Estrogen Exposure is Associated with Postmenopausal Fracture Risk: The Women's Health Initiative Study.
    J Bone Miner Res. 2022 May 29. doi: 10.1002/jbmr.4613.
    PubMed     Abstract available


  8. SOLLMANN N, Loffler MT, El Husseini M, Sekuboyina A, et al
    Automated opportunistic osteoporosis screening in routine computed tomography of the spine - comparison with dedicated quantitative CT.
    J Bone Miner Res. 2022 May 22. doi: 10.1002/jbmr.4575.
    PubMed     Abstract available


  9. WILLIAMS DW, Ho K, Lenon A, Kim S, et al
    Long-term ligature-induced periodontitis exacerbates development of bisphosphonate-related osteonecrosis of the jaw in mice.
    J Bone Miner Res. 2022 May 22. doi: 10.1002/jbmr.4614.
    PubMed     Abstract available


  10. ODA T, Jodicke AM, Robinson DE, Delmestri A, et al
    Oral bisphosphonates are associated with increased risk of severe acute kidney injury in elderly patients with complex health needs: a self-controlled case series in the UK.
    J Bone Miner Res. 2022 May 17. doi: 10.1002/jbmr.4573.
    PubMed     Abstract available


  11. BAILEY S, Stadelmann MA, Zysset PK, Vashishth D, et al
    Influence of Metastatic Bone Lesion Type and Tumor Origin on Human Vertebral Bone Architecture, Matrix Quality, and Mechanical Properties.
    J Bone Miner Res. 2022;37:896-907.
    PubMed     Abstract available


  12. FARLAY D, Rizzo S, Dempster DW, Huang S, et al
    Bone Mineral and Organic Properties in Postmenopausal Women Treated With Denosumab for Up to 10 years.
    J Bone Miner Res. 2022;37:856-864.
    PubMed     Abstract available


    April 2022
  13. VISSER JA
    Serum AMH levels: an early reproductive marker for bone loss?
    J Bone Miner Res. 2022 Apr 30. doi: 10.1002/jbmr.4567.
    PubMed    


  14. MILLER PD, Adachi JD, Albergaria BH, Cheung AM, et al
    Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease.
    J Bone Miner Res. 2022 Apr 24. doi: 10.1002/jbmr.4563.
    PubMed     Abstract available


  15. ZHENG Z, Johansson H, Harvey NC, Lorentzon M, et al
    Potential Adverse Effect of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) on Bisphosphonate Efficacy: An Exploratory Post Hoc Analysis From a Randomized Controlled Trial of Clodronate.
    J Bone Miner Res. 2022 Apr 20. doi: 10.1002/jbmr.4548.
    PubMed     Abstract available


  16. ZHU DL, Chen XF, Zhou XR, Hu SY, et al
    An osteoporosis susceptibility allele at 11p15 regulates SOX6 expression by modulating TCF4 chromatin binding.
    J Bone Miner Res. 2022 Apr 4. doi: 10.1002/jbmr.4554.
    PubMed     Abstract available


  17. KARLAMANGLA AS, Shieh A, Greendale GA, Yu EW, et al
    Anti-Mullerian Hormone as Predictor of Future and Ongoing Bone Loss During the Menopause Transition.
    J Bone Miner Res. 2022 Apr 4. doi: 10.1002/jbmr.4525.
    PubMed     Abstract available


  18. LI R, Medina-Gomez C, Rivadeneira F
    Down-to-Earth Studies of the Gut Microbiome in Bone Health and Disease.
    J Bone Miner Res. 2022;37:595-596.
    PubMed    


  19. ORWOLL ES, Parimi N, Wiedrick J, Lapidus J, et al
    Analysis of the Associations Between the Human Fecal Microbiome and Bone Density, Structure, and Strength: The Osteoporotic Fractures in Men (MrOS) Cohort.
    J Bone Miner Res. 2022;37:597-607.
    PubMed     Abstract available


    March 2022
  20. KATO H, Ansh AJ, Lester ER, Kinoshita Y, et al
    Identification of ENPP1 haploinsufficiency in patients with diffuse idiopathic skeletal hyperostosis and early-onset osteoporosis.
    J Bone Miner Res. 2022 Mar 26. doi: 10.1002/jbmr.4550.
    PubMed     Abstract available


  21. GEUSENS P, Bevers MSAM, van Rietbergen B, Messina OD, et al
    Effect of denosumab compared to risedronate on bone strength in patients initiating or continuing glucocorticoid treatment.
    J Bone Miner Res. 2022 Mar 26. doi: 10.1002/jbmr.4551.
    PubMed     Abstract available


  22. CHANDRAN M, Ebeling PR, Mitchell PJ, Nguyen TV, et al
    Harmonization of osteoporosis guidelines. Paving the way for disrupting the status quo in osteoporosis management in the Asia Pacific.
    J Bone Miner Res. 2022 Mar 12. doi: 10.1002/jbmr.4544.
    PubMed     Abstract available


  23. CHANDRA A, Lagnado AB, Farr JN, Schleusner M, et al
    Bone marrow adiposity in models of radiation- and aging-related bone loss is dependent on cellular senescence.
    J Bone Miner Res. 2022 Mar 5. doi: 10.1002/jbmr.4537.
    PubMed     Abstract available


  24. ADAMI G, Fassio A, Gatti D, Viapiana O, et al
    Acute Phase Reaction and Fracture Risk Reduction. Are Gamma-Delta T Cells and hypovitaminosis D the Missing Link?
    J Bone Miner Res. 2022 Mar 1. doi: 10.1002/jbmr.4534.
    PubMed    


  25. ZHANG L, Fu X, Ni L, Liu C, et al
    Hedgehog Signaling Controls Bone Homeostasis by Regulating Osteogenic/Adipogenic Fate of Skeletal Stem/Progenitor Cells in Mice.
    J Bone Miner Res. 2022;37:559-576.
    PubMed     Abstract available


    February 2022
  26. BLIUC D, Tran T, Adachi JD, Atkins GJ, et al
    The association between cognitive decline and bone loss and fracture risk is not affected by medication with anticholinergic effect.
    J Bone Miner Res. 2022 Feb 23. doi: 10.1002/jbmr.4530.
    PubMed    


  27. POOLE KE, Treece GM, Pearson RA, Gee AH, et al
    Romosozumab Enhances Vertebral Bone Structure in Women With Low Bone Density.
    J Bone Miner Res. 2022;37:256-264.
    PubMed     Abstract available


    January 2022
  28. KAYA S, Schurman CA, Dole NS, Evans DS, et al
    Prioritization of genes relevant to bone fragility through the unbiased integration of aging mouse bone transcriptomics and human GWAS analyses.
    J Bone Miner Res. 2022 Jan 29. doi: 10.1002/jbmr.4516.
    PubMed     Abstract available


  29. NAHARCI MI
    Comment on a recent article titled "Cognitive decline is associated with an accelerated rate of bone loss and increased fracture risk in women: a prospective study from the Canadian Multicentre Osteoporosis Study".
    J Bone Miner Res. 2022 Jan 23. doi: 10.1002/jbmr.4510.
    PubMed    


  30. SADOUGHI S, Pasco C, Joseph GB, Wu PH, et al
    Cortical bone loss following gastric bypass surgery is not primarily endocortical.
    J Bone Miner Res. 2022 Jan 23. doi: 10.1002/jbmr.4512.
    PubMed     Abstract available


  31. TSOURDI E
    RANKL blockade reduces cachexia and bone loss induced by non-metastatic ovarian cancer in mice - Editorial.
    J Bone Miner Res. 2022 Jan 23. doi: 10.1002/jbmr.4511.
    PubMed    


  32. WOODS GN, Ewing SK, Schafer AL, Gudnason V, et al
    Saturated and Unsaturated Bone Marrow Lipids Have Distinct Effects on Bone Density and Fracture Risk in Older Adults.
    J Bone Miner Res. 2022 Jan 17. doi: 10.1002/jbmr.4504.
    PubMed     Abstract available


  33. WU KC, Black DM
    A Perspective on Postmenopausal Bone Loss with Aging.
    J Bone Miner Res. 2022 Jan 5. doi: 10.1002/jbmr.4499.
    PubMed    


  34. ERIKSEN EF, Chapurlat R, Boyce RW, Shi Y, et al
    Modeling-Based Bone Formation After 2 Months of Romosozumab Treatment: Results From the FRAME Clinical Trial.
    J Bone Miner Res. 2022;37:36-40.
    PubMed     Abstract available


  35. ICONARU L, Charles A, Baleanu F, Surquin M, et al
    Prediction of an Imminent Fracture After an Index Fracture - Models Derived From the Frisbee Cohort.
    J Bone Miner Res. 2022;37:59-67.
    PubMed     Abstract available


  36. MA Q, Wang S, Xie Z, Shen Y, et al
    The SFRP1 Inhibitor WAY-316606 Attenuates Osteoclastogenesis Through Dual Modulation of Canonical Wnt Signaling.
    J Bone Miner Res. 2022;37:152-166.
    PubMed     Abstract available


    December 2021
  37. WHITTIER DE, Samelson EJ, Hannan MT, Burt LA, et al
    Bone microarchitecture phenotypes identified in older adults are associated with different levels of osteoporotic fracture risk.
    J Bone Miner Res. 2021 Dec 25. doi: 10.1002/jbmr.4494.
    PubMed     Abstract available


  38. KASHER M, Freidin MB, Williams FM, Cherny SS, et al
    Shared genetic architecture between rheumatoid arthritis and varying osteoporotic phenotypes.
    J Bone Miner Res. 2021 Dec 15. doi: 10.1002/jbmr.4491.
    PubMed     Abstract available


  39. PIN F, Jones AJ, Huot JR, Narasimhan A, et al
    RANKL Blockade Reduces Cachexia and Bone Loss Induced by Non-Metastatic Ovarian Cancer in Mice.
    J Bone Miner Res. 2021 Dec 13. doi: 10.1002/jbmr.4480.
    PubMed     Abstract available


  40. CHEUNG WH, Hung VW, Cheuk KY, Chau WW, et al
    Best Performance Parameters of HR-pQCT to Predict Fragility Fracture: Systematic Review and Meta-Analysis.
    J Bone Miner Res. 2021;36:2381-2398.
    PubMed     Abstract available


  41. LIU J, Laster A, Xu X, Guo H, et al
    Patterns of Teriparatide and Sequential Antiresorptive Agent Treatment Among Elderly Female Medicare Beneficiaries.
    J Bone Miner Res. 2021;36:2309-2316.
    PubMed     Abstract available


    November 2021
  42. ALAJLOUNI D, Tran T, Bliuc D, Blank RD, et al
    Muscle Strength and Physical Performance Improve Fracture Risk Prediction beyond Garvan and FRAX: The Osteoporotic Fractures in Men (MrOS) Study.
    J Bone Miner Res. 2021 Nov 29. doi: 10.1002/jbmr.4483.
    PubMed     Abstract available


  43. OTT SM
    Consider the bisphosphonate dose.
    J Bone Miner Res. 2021 Nov 29. doi: 10.1002/jbmr.4479.
    PubMed    


  44. DHALIWAL R, Ewing SK, Vashishth D, Semba RD, et al
    Greater Carboxy-Methyl-Lysine Is Associated With Increased Fracture Risk in Type 2 Diabetes.
    J Bone Miner Res. 2021 Nov 24. doi: 10.1002/jbmr.4466.
    PubMed     Abstract available


  45. JANG M, Kim M, Bae SJ, Lee SH, et al
    Opportunistic osteoporosis screening using chest radiographs with deep learning: Development and external validation with a cohort dataset.
    J Bone Miner Res. 2021 Nov 23. doi: 10.1002/jbmr.4477.
    PubMed     Abstract available


  46. KIM HJ, Ryu KY, Kim YG, Kim MO, et al
    Myeloid-specific PTP1B deficiency attenuates inflammation- and ovariectomy-induced bone loss in mice by inhibiting osteoclastogenesis.
    J Bone Miner Res. 2021 Nov 23. doi: 10.1002/jbmr.4478.
    PubMed     Abstract available


  47. JUDITH EG, Daniel L, John-Patrik B, Benoit S, et al
    Risk of Osteonecrosis of the Jaw under Denosumab Compared to Bisphosphonates in Patients with Osteoporosis.
    J Bone Miner Res. 2021 Nov 17. doi: 10.1002/jbmr.4472.
    PubMed     Abstract available


  48. TSUJITA M, Doi Y, Obi Y, Hamano T, et al
    Cholecalciferol supplementation attenuates bone loss in incident kidney transplant recipients: A prespecified secondary endpoint analysis of a randomized controlled trial.
    J Bone Miner Res. 2021 Nov 8. doi: 10.1002/jbmr.4469.
    PubMed     Abstract available


  49. BROWN JP, Engelke K, Keaveny TM, Chines A, et al
    Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial.
    J Bone Miner Res. 2021;36:2139-2152.
    PubMed     Abstract available


    October 2021
  50. GREGSON CL, Madanhire T, Rehman A, Ferrand RA, et al
    Osteoporosis, rather than sarcopenia, is the predominant musculoskeletal disease in a rural South African community where HIV prevalence is high: a cross-sectional study.
    J Bone Miner Res. 2021 Oct 25. doi: 10.1002/jbmr.4464.
    PubMed     Abstract available


  51. BEGIN MJ, Audet MC, Chevalley T, Portela M, et al
    Fracture risk following an atypical femoral fracture.
    J Bone Miner Res. 2021 Oct 20. doi: 10.1002/jbmr.4461.
    PubMed     Abstract available


  52. MOILANEN A, Kopra J, Kroger H, Sund R, et al
    Characteristics of Long-Term Femoral Neck Bone Loss in Postmenopausal Women: A 25-Year Follow-Up.
    J Bone Miner Res. 2021 Oct 19. doi: 10.1002/jbmr.4444.
    PubMed     Abstract available


  53. FISCHER V, Ragipoglu D, Diedrich J, Steppe L, et al
    Mast cells trigger disturbed bone healing in osteoporotic mice.
    J Bone Miner Res. 2021 Oct 11. doi: 10.1002/jbmr.4455.
    PubMed     Abstract available


  54. FUSARO M, Cianciolo G, Tripepi G, Plebani M, et al
    Oral Calcitriol Use, Vertebral Fractures, and Vitamin K in Hemodialysis Patients: A Cross-Sectional Study.
    J Bone Miner Res. 2021 Oct 8. doi: 10.1002/jbmr.4440.
    PubMed     Abstract available


  55. VERWAAIJEN EJ, Ma J, de Groot-Kruseman HA, Pieters R, et al
    A Validated Risk Prediction Model for Bone Fragility in Children With Acute Lymphoblastic Leukemia.
    J Bone Miner Res. 2021 Oct 5. doi: 10.1002/jbmr.4442.
    PubMed     Abstract available


  56. NOEL SE, Santos MP, Wright NC
    Racial and Ethnic Disparities in Bone Health and Outcomes in the United States.
    J Bone Miner Res. 2021;36:1881-1905.
    PubMed     Abstract available


  57. ZWEIFLER LE, Koh AJ, Daignault-Newton S, McCauley LK, et al
    Anabolic actions of PTH in murine models: two decades of insights.
    J Bone Miner Res. 2021;36:1979-1998.
    PubMed     Abstract available


    September 2021
  58. SKULADOTTIR SS, Ramel A, Eymundsdottir H, Hjaltadottir I, et al
    Serum 25-hydroxy-vitamin D status and incident hip fractures in elderly adults: Looking beyond bone mineral density.
    J Bone Miner Res. 2021 Sep 29. doi: 10.1002/jbmr.4450.
    PubMed    


  59. BANEFELT J, Timoshanko J, Soreskog E, Ortsater G, et al
    Total Hip Bone Mineral Density as an Indicator of Fracture Risk in Bisphosphonate-Treated Patients in a Real-World Setting.
    J Bone Miner Res. 2021 Sep 29. doi: 10.1002/jbmr.4448.
    PubMed     Abstract available


  60. GREY A, Bolland MJ, Horne A, Mihov B, et al
    Bone mineral density and bone turnover ten years after a single 5mg dose or two 5-yearly lower doses of zoledronate in osteopenic older women: an open-label extension of a randomized controlled trial.
    J Bone Miner Res. 2021 Sep 29. doi: 10.1002/jbmr.4453.
    PubMed     Abstract available


  61. BLACK DM, Reid IR, Napoli N, Ewing SK, et al
    The Interaction of Acute-Phase Reaction and Efficacy for Osteoporosis After Zoledronic Acid: HORIZON Pivotal Fracture Trial.
    J Bone Miner Res. 2021 Sep 28. doi: 10.1002/jbmr.4434.
    PubMed     Abstract available


  62. SINGHANIA P, Bhattacharjee R
    Letter to editor regarding "Durability and delayed treatment effects of zoledronic acid on bone loss after spinal cord injury: A randomized, controlled trial" by W. Brent Edwards.
    J Bone Miner Res. 2021 Sep 20. doi: 10.1002/jbmr.4446.
    PubMed    


  63. LARY CW, Rosen CJ, Kiel DP
    Osteoporosis and dementia: establishing a link.
    J Bone Miner Res. 2021 Sep 13. doi: 10.1002/jbmr.4431.
    PubMed    


  64. BEAUDOIN C, Jean S, Moore L, Gamache P, et al
    Prediction of Osteoporotic Fractures in Elderly Individuals: a Derivation and Internal Validation Study Using Healthcare Administrative Data.
    J Bone Miner Res. 2021 Sep 7. doi: 10.1002/jbmr.4438.
    PubMed     Abstract available


    August 2021
  65. GINSBERG C, Hoofnagle AN, Katz R, Hughes-Austin J, et al
    The Vitamin D Metabolite Ratio is Associated with Changes in Bone Density and Fracture Risk in Older Adults.
    J Bone Miner Res. 2021 Aug 23. doi: 10.1002/jbmr.4426.
    PubMed     Abstract available



  66. Retraction Statement: Bone Mineral Density Predicts Fractures in Chronic Kidney Disease.
    J Bone Miner Res. 2021 Aug 19. doi: 10.1002/jbmr.4421.
    PubMed    


  67. DEGLI ESPOSTI L, Perrone V, Sangiorgi D, Andretta M, et al
    The Use of Oral Amino-Bisphosphonates and COVID-19 Outcomes.
    J Bone Miner Res. 2021 Aug 18. doi: 10.1002/jbmr.4419.
    PubMed     Abstract available


  68. HAINES MS, Kimball A, Meenaghan E, Bachmann KN, et al
    Sequential therapy with recombinant human IGF-1 followed by risedronate increases spine bone mineral density in women with anorexia nervosa: A randomized, placebo-controlled trial.
    J Bone Miner Res. 2021 Aug 6. doi: 10.1002/jbmr.4420.
    PubMed     Abstract available


  69. KHALID S, Pineda Moncusi M, El-Hussein L, Delmestri A, et al
    Predicting imminent fractures in patients with a recent fracture or starting oral bisphosphonate therapy: development and international validation of prognostic models.
    J Bone Miner Res. 2021 Aug 3. doi: 10.1002/jbmr.4414.
    PubMed     Abstract available


  70. KLINE GA, Lix LM, Leslie WD
    Patient Outcomes in the Years After a DXA-BMD Treatment Monitoring Test: Improved Medication Adherence in Some, But Too Little Too Late.
    J Bone Miner Res. 2021;36:1425-1431.
    PubMed     Abstract available


    July 2021
  71. BLIUC D, Tran T, Adachi JD, Atkins GJ, et al
    Cognitive decline is associated with an accelerated rate of bone loss and increased fracture risk in women: a prospective study from the Canadian Multicentre Osteoporosis Study.
    J Bone Miner Res. 2021 Jul 20. doi: 10.1002/jbmr.4402.
    PubMed     Abstract available


  72. BATOON L, Millard SM, Raggatt LJ, Wu AC, et al
    Osteal macrophages support osteoclast-mediated resorption and contribute to bone pathology in a postmenopausal osteoporosis mouse model.
    J Bone Miner Res. 2021 Jul 19. doi: 10.1002/jbmr.4413.
    PubMed     Abstract available


  73. EDWARDS WB, Haider IT, Simonian N, Barroso J, et al
    Durability and delayed treatment effects of zoledronic acid on bone loss after spinal cord injury: A randomized, controlled trial.
    J Bone Miner Res. 2021 Jul 19. doi: 10.1002/jbmr.4416.
    PubMed     Abstract available


    June 2021
  74. CHEN J, Zhang J, So HC, Ai S, et al
    Association of sleep traits and heel bone mineral density: Observational and Mendelian randomization studies.
    J Bone Miner Res. 2021 Jun 29. doi: 10.1002/jbmr.4406.
    PubMed     Abstract available


  75. MICHAELSSON K, Byberg L, Svennblad B, Larsson SC, et al
    Serum 25-hydroxyvitamin D is associated with fracture risk only during periods of seasonally high levels in women with a high BMI.
    J Bone Miner Res. 2021 Jun 25. doi: 10.1002/jbmr.4400.
    PubMed     Abstract available


  76. DOWNEY J
    Erratum for Identification of an Epigenetic Signature of Osteoporosis in Blood DNA of Postmenopausal Women.
    J Bone Miner Res. 2021 Jun 22. doi: 10.1002/jbmr.4392.
    PubMed    


  77. CHAKHTOURA M, Dagher H, Sharara S, Ajjour S, et al
    Systematic review of major osteoporotic fracture to hip fracture incidence rate ratios worldwide: Implications to FRAX derived estimates.
    J Bone Miner Res. 2021 Jun 21. doi: 10.1002/jbmr.4395.
    PubMed     Abstract available


  78. REID IR
    Monitoring Osteoporosis Therapy.
    J Bone Miner Res. 2021 Jun 16. doi: 10.1002/jbmr.4393.
    PubMed    


  79. YU XH, Wei YY, Zeng P, Lei SF, et al
    Birth weight is positively associated with adult osteoporosis risk: observational and Mendelian randomization studies.
    J Bone Miner Res. 2021 Jun 9. doi: 10.1002/jbmr.4316.
    PubMed     Abstract available


  80. BANDO K, Kuroishi T, Tada H, Oizumi T, et al
    Nitrogen-containing Bisphosphonates and Lipopolysaccharide Mutually Augment Inflammation via ATP- and IL-1beta-mediated Production of NETs.
    J Bone Miner Res. 2021 Jun 2. doi: 10.1002/jbmr.4384.
    PubMed     Abstract available


    May 2021
  81. KISTLER-FISCHBACHER M, Yong JS, Weeks BK, Beck BR, et al
    A Comparison of Bone-Targeted Exercise With and Without Antiresorptive Bone Medication to Reduce Indices of Fracture Risk in Postmenopausal Women With Low Bone Mass: The MEDEX-OP Randomized Controlled Trial.
    J Bone Miner Res. 2021 May 25. doi: 10.1002/jbmr.4334.
    PubMed     Abstract available


  82. DUTTA A, Bhadada SK, Walia R
    Anabolic Window-Like Phenomenon After Biochemical Remission in Cushing's Syndrome: Does Surge in Bone Turnover Markers Correlate With Improved Bone Mineral Density?
    J Bone Miner Res. 2021 May 24. doi: 10.1002/jbmr.4337.
    PubMed    


  83. BEK JW, Shochat C, De Clercq A, De Saffel H, et al
    Lrp5 mutant and crispant zebrafish faithfully model human osteoporosis, establishing the zebrafish as a platform for CRISPR-based functional screening of osteoporosis candidate genes.
    J Bone Miner Res. 2021 May 6. doi: 10.1002/jbmr.4327.
    PubMed     Abstract available


  84. WANG S, Ma Q, Xie Z, Shen Y, et al
    An anti-oxidant sesquiterpene inhibits osteoclastogenesis via blocking IPMK/TRAF6 and counteracts OVX-induced osteoporosis in mice.
    J Bone Miner Res. 2021 May 6. doi: 10.1002/jbmr.4328.
    PubMed     Abstract available


  85. RAMCHAND SK, David NL, Lee H, Eastell R, et al
    Efficacy of Zoledronic Acid in Maintaining Areal and Volumetric Bone Density After Combined Denosumab and Teriparatide Administration: DATA-HD Study Extension.
    J Bone Miner Res. 2021;36:921-930.
    PubMed     Abstract available


    April 2021
  86. JOHANSSON L, Lorentzon M
    Reply to: Grade 1 vertebral fractures, bone mineral density, and the risk of fractures.
    J Bone Miner Res. 2021 Apr 26. doi: 10.1002/jbmr.4301.
    PubMed    


  87. KHAIRALLAH P, Nickolas TL
    Bisphosphonates in Kidney Disease-Safety First.
    J Bone Miner Res. 2021 Apr 26. doi: 10.1002/jbmr.4283.
    PubMed    


  88. KANTEREWICZ E, Puigoriol E, Peris P
    Grade 1 vertebral fractures, bone mineral density, and the risk of fractures.
    J Bone Miner Res. 2021 Apr 20. doi: 10.1002/jbmr.4302.
    PubMed    


  89. BONNET N, Douni E, Perreard Lopreno G, Besse M, et al
    RANKL-induced increase in cathepsin K levels restricts cortical expansion in a periostin dependent fashion: a potential new mechanism of bone fragility.
    J Bone Miner Res. 2021 Apr 15. doi: 10.1002/jbmr.4307.
    PubMed     Abstract available


  90. TSOURDI E, Yu EW, Jan de Beur SM, Drake MT, et al
    Vaccination for Covid-19 and relationship to osteoporosis care: Current evidence and suggested approaches.
    J Bone Miner Res. 2021 Apr 8. doi: 10.1002/jbmr.4304.
    PubMed     Abstract available


  91. HARVEY NC, Orwoll E, Kwok T, Karlsson MK, et al
    Sarcopenia Definitions as Predictors of Fracture Risk Independent of FRAX((R)) , Falls, and BMD in the Osteoporotic Fractures in Men (MrOS) Study: A Meta-Analysis.
    J Bone Miner Res. 2021 Apr 8. doi: 10.1002/jbmr.4293.
    PubMed     Abstract available


  92. SOLLING AS, Harslof T, Langdahl B
    Treatment with zoledronate subsequent to denosumab in osteoporosis: a 2-year randomized study.
    J Bone Miner Res. 2021 Apr 4. doi: 10.1002/jbmr.4305.
    PubMed     Abstract available


    March 2021
  93. MA B, Li C, Pan J, Zhang S, et al
    Causal Associations of Anthropometric Measurements with Fracture Risk and Bone Mineral Density: A Mendelian Randomization Study.
    J Bone Miner Res. 2021 Mar 30. doi: 10.1002/jbmr.4296.
    PubMed     Abstract available


  94. MA J, Siminoski K, Wang P, Jaremko JL, et al
    The Accuracy of Incident Vertebral Fracture Detection in Children Using Targeted Case-Finding Approaches.
    J Bone Miner Res. 2021 Mar 30. doi: 10.1002/jbmr.4294.
    PubMed     Abstract available


  95. SMETS J, Shevroja E, Hugle T, Leslie WD, et al
    Machine learning Solutions for Osteoporosis - a Review.
    J Bone Miner Res. 2021 Mar 22. doi: 10.1002/jbmr.4292.
    PubMed     Abstract available


  96. SCHOUSBOE JT, Langsetmo L, Szulc P, Lewis JR, et al
    Joint Associations of Prevalent Radiographic Vertebral Fracture and Abdominal Aortic Calcification With Incident Hip, Major Osteoporotic, and Clinical Vertebral Fractures.
    J Bone Miner Res. 2021 Mar 17. doi: 10.1002/jbmr.4257.
    PubMed     Abstract available


  97. PAPAPOULOS S, Bone H, Cosman F, Dempster DW, et al
    Incidence of Hip and Subtrochanteric/Femoral Shaft Fractures in Postmenopausal Women with Osteoporosis in the Phase 3 Long-Term Odanacatib Fracture Trial.
    J Bone Miner Res. 2021 Mar 16. doi: 10.1002/jbmr.4284.
    PubMed     Abstract available


  98. GANESAN C, Thomas IC, Romero R, Song S, et al
    Osteoporosis, Fractures, and Bone Mineral Density Screening in Veterans With Kidney Stone Disease.
    J Bone Miner Res. 2021 Mar 3. doi: 10.1002/jbmr.4260.
    PubMed     Abstract available


  99. SENAY A, Fernandes JC, Delisle J, Morin SN, et al
    Patient Healthcare Trajectory and its Impact on the Cost-Effectiveness of Fracture Liaison Services.
    J Bone Miner Res. 2021;36:459-468.
    PubMed     Abstract available


    February 2021
  100. ENSRUD KE, Schousboe JT, Kats AM, Vo TN, et al
    Height Loss in Old Age and Fracture Risk Among Men in Late Life: A Prospective Cohort Study.
    J Bone Miner Res. 2021 Feb 22. doi: 10.1002/jbmr.4278.
    PubMed     Abstract available


  101. COLAIANNI G, Errede M, Sanesi L, Notarnicola A, et al
    In Reply to the Letter to the Editor: Involvement of Irisin in Age-Related Osteoporosis and Its Inhibitory Effect on the Senescent Marker p21 in Osteoblasts.
    J Bone Miner Res. 2021 Feb 18. doi: 10.1002/jbmr.4268.
    PubMed    


  102. SCHOUSBOE JT, Ensrud KE
    Opportunistic Osteoporosis Screening Using Low-Dose Computed Tomography (LDCT): Promising Strategy, but Challenges Remain.
    J Bone Miner Res. 2021 Feb 18. doi: 10.1002/jbmr.4266.
    PubMed    


  103. WEIGL M, Kocijan R, Ferguson J, Leinfellner G, et al
    Longitudinal Changes of Circulating miRNAs during Bisphosphonate and Teriparatide Treatment in an Animal Model of Postmenopausal Osteoporosis.
    J Bone Miner Res. 2021 Feb 17. doi: 10.1002/jbmr.4276.
    PubMed     Abstract available


  104. FOLKESTAD L, Stochholm K, Groth K, Hove H, et al
    Fracture Rates and Fracture Risk in Patients With Marfan Syndrome: A Nationwide Register-Based Cohort Study.
    J Bone Miner Res. 2021 Feb 10. doi: 10.1002/jbmr.4258.
    PubMed     Abstract available


  105. MAZESS RB
    Vitamin D Supplements: Is Bone Loss by pQCT Really Negative?
    J Bone Miner Res. 2021 Feb 3. doi: 10.1002/jbmr.4246.
    PubMed    


  106. BURT LA, Billington EO, Rose MS, Kremer R, et al
    Reply to Vitamin D Supplements: Is Bone Loss by HR-pQCT Really Negative?
    J Bone Miner Res. 2021 Feb 3. doi: 10.1002/jbmr.4247.
    PubMed    


  107. LEWIS JR, Voortman T, Ioannidis JP
    Evaluating and Strengthening the Evidence for Nutritional Bone Research: Ready to Break New Ground?
    J Bone Miner Res. 2021;36:219-226.
    PubMed     Abstract available


  108. GILSENAN A, Midkiff K, Harris D, Kellier-Steele N, et al
    Teriparatide Did Not Increase Adult Osteosarcoma Incidence in a 15-Year US Postmarketing Surveillance Study.
    J Bone Miner Res. 2021;36:244-251.
    PubMed     Abstract available


    January 2021
  109. LU H, Lei X, Zhao H, Elting L, et al
    Bone Mineral Density at the Time of Initiating Aromatase Inhibitor Therapy is Associated with Decreased Fractures in Women with Breast Cancer.
    J Bone Miner Res. 2021 Jan 23. doi: 10.1002/jbmr.4250.
    PubMed     Abstract available


  110. BING L, Jie Z, Jianxiong M, Weibo C, et al
    Crosstalk between histone and DNA methylation mediates bone loss in hind limb unloading.
    J Bone Miner Res. 2021 Jan 19. doi: 10.1002/jbmr.4253.
    PubMed     Abstract available


  111. DEMPSTER DW, Zhou H, Rao SD, Recknor C, et al
    Early Effects of Abaloparatide on Bone Formation and Resorption Indices in Postmenopausal Women with Osteoporosis.
    J Bone Miner Res. 2021 Jan 12. doi: 10.1002/jbmr.4243.
    PubMed     Abstract available


  112. ZHANG X, Xu H, Li GHY, Long MT, et al
    Metabolomics insights into osteoporosis through association with bone mineral density.
    J Bone Miner Res. 2021 Jan 12. doi: 10.1002/jbmr.4240.
    PubMed     Abstract available


  113. FARLAY D, Rizzo S, Ste-Marie LG, Michou L, et al
    Duration-Dependent Increase of Human Bone Matrix Mineralization in Long-Term Bisphosphonate Users with Atypical Femur Fracture.
    J Bone Miner Res. 2021 Jan 12. doi: 10.1002/jbmr.4244.
    PubMed     Abstract available


    December 2020
  114. HAYES KN, Giannakeas V, Wong AKO
    Response to: Challenges to the Possible Use of Bisphosphonates in Early-Stage Osteoarthritis.
    J Bone Miner Res. 2020 Dec 30. doi: 10.1002/jbmr.4232.
    PubMed    


  115. ROBINSON DE, Ali MS, Pallares N, Tebe C, et al
    Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a bi-national cohort analysis.
    J Bone Miner Res. 2020 Dec 29. doi: 10.1002/jbmr.4235.
    PubMed     Abstract available


  116. IM C, Li N, Moon W, Liu Q, et al
    Genome-wide association studies reveal novel locus with sex-/therapy-specific fracture risk effects in childhood cancer survivors.
    J Bone Miner Res. 2020 Dec 18. doi: 10.1002/jbmr.4234.
    PubMed     Abstract available


  117. RAJAPAKSE CS, Johncola AJ, Batzdorf AS, Jones BC, et al
    Effect of Low Intensity Vibration on Bone Strength, Microstructure, and Adiposity in Pre-Osteoporotic Postmenopausal Women: A Randomized Placebo-Controlled Trial.
    J Bone Miner Res. 2020 Dec 13. doi: 10.1002/jbmr.4229.
    PubMed     Abstract available


  118. NG CA, Scott D, Seibel MJ, Cumming RG, et al
    Higher Impact Physical Activity is Associated with Maintenance of Bone Mineral Density but Not Reduced Incident Falls or Fractures in Older Men: The Concord Health and Ageing in Men Project.
    J Bone Miner Res. 2020 Dec 5. doi: 10.1002/jbmr.4228.
    PubMed     Abstract available


    November 2020
  119. MOKHTARZADEH H, Anderson DE, Allaire BT, Bouxsein ML, et al
    Patterns of load-to-strength ratios along the spine in a population-based cohort to evaluate the contribution of spinal loading to vertebral fractures.
    J Bone Miner Res. 2020 Nov 30. doi: 10.1002/jbmr.4222.
    PubMed     Abstract available


  120. YAU MS, Kuipers AL, Price R, Nicolas A, et al
    A meta-analysis of the transferability of bone mineral density genetic loci associations from European to African ancestry populations.
    J Bone Miner Res. 2020 Nov 29. doi: 10.1002/jbmr.4220.
    PubMed     Abstract available


  121. BROMILEY PA, Clark EM, Poole KE
    Computer-Aided Diagnostic Systems for Osteoporotic Vertebral Fracture Detection: Opportunities and Challenges.
    J Bone Miner Res. 2020 Nov 14. doi: 10.1002/jbmr.4205.
    PubMed    


  122. FUSARO M, Cozzolino M, Plebani M, Iervasi G, et al
    Sevelamer use, vitamin K levels, vascular calcifications and vertebral fractures in hemodialysis patients: results from the VIKI study.
    J Bone Miner Res. 2020 Nov 14. doi: 10.1002/jbmr.4214.
    PubMed     Abstract available


  123. ZHANG C, Zhu J, Jia J, Guan Z, et al
    Effect of Single Versus Multiple Fractures on Systemic Bone Loss in Mice.
    J Bone Miner Res. 2020 Nov 12. doi: 10.1002/jbmr.4211.
    PubMed     Abstract available


  124. CHENG X, Zhao K, Zha X, Du X, et al
    Opportunistic Screening Using Low-Dose CT and the Prevalence of Osteoporosis in China: A Nationwide, Multicenter Study.
    J Bone Miner Res. 2020 Nov 4. doi: 10.1002/jbmr.4187.
    PubMed     Abstract available


  125. SUGIYAMA T
    Effects of High-Dose Vitamin D Supplementation on Bone Fragility.
    J Bone Miner Res. 2020 Nov 2. doi: 10.1002/jbmr.4194.
    PubMed    


    October 2020
  126. LEE JM, Kim MJ, Lee SJ, Kim BG, et al
    PDK2 deficiency prevents ovariectomy-induced bone loss in mice by regulating the RANKL-NFATc1 pathway during osteoclastogenesis.
    J Bone Miner Res. 2020 Oct 30. doi: 10.1002/jbmr.4202.
    PubMed     Abstract available


  127. STURZNICKEL J, Rolvien T, Delsmann A, Butscheidt S, et al
    Clinical phenotype and relevance of LRP5 and LRP6 variants in patients with early-onset osteoporosis (EOOP).
    J Bone Miner Res. 2020 Oct 29. doi: 10.1002/jbmr.4197.
    PubMed     Abstract available


  128. ZENGIN A, Jarjou LM, Janha RE, Prentice A, et al
    Sex-specific associations between cardiac workload, peripheral vascular calcification and bone mineral density: The Gambian Bone and Muscle Ageing Study.
    J Bone Miner Res. 2020 Oct 29. doi: 10.1002/jbmr.4196.
    PubMed     Abstract available


  129. BURT LA, Billington EO, Rose MS, Kremer R, et al
    Reply to Effects of High-Dose Vitamin D Supplementation on Bone Fragility.
    J Bone Miner Res. 2020 Oct 23. doi: 10.1002/jbmr.4190.
    PubMed    


  130. WARD KA
    Bone Loss and Lactation in Women Living With HIV: Potential Implications for Long-Term Bone Health.
    J Bone Miner Res. 2020 Oct 5. doi: 10.1002/jbmr.4183.
    PubMed    


    September 2020
  131. TALEVSKI J, Sanders KM, Busija L, Beauchamp A, et al
    Health Service Use and Quality of Life Recovery 12-months Following Major Osteoporotic Fracture: Latent Class Analyses of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS).
    J Bone Miner Res. 2020 Sep 22. doi: 10.1002/jbmr.4181.
    PubMed     Abstract available


  132. ZHOU J, Zhang Q, Liu X
    Challenges to the Possible Use of Bisphosphonates in Early-Stage Osteoarthritis.
    J Bone Miner Res. 2020 Sep 19. doi: 10.1002/jbmr.4172.
    PubMed    


  133. EASTELL R, Black DM, Lui LY, Chines A, et al
    Treatment-Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Antiresorptive Drugs: Proportion of Treatment Effect Explained.
    J Bone Miner Res. 2020 Sep 11. doi: 10.1002/jbmr.4178.
    PubMed     Abstract available


  134. ADAMI G, Fassio A, Giollo A, Orsolini G, et al
    Could Previous Exposure to Nitrogen-Containing Bisphosphonates Mitigate Friendly Fire?
    J Bone Miner Res. 2020 Sep 4. doi: 10.1002/jbmr.4163.
    PubMed    


  135. ZHANG B, Zhang S
    Corticosteroid-Induced Osteonecrosis in COVID-19: A Call For Caution.
    J Bone Miner Res. 2020;35:1828-1829.
    PubMed    


    August 2020
  136. REID IR, Horne AM, Mihov B, Stewart A, et al
    Predictors of Fracture in Older Women with Osteopenic Hip Bone Mineral Density Treated with Zoledronate.
    J Bone Miner Res. 2020 Aug 24. doi: 10.1002/jbmr.4167.
    PubMed     Abstract available


  137. GENNARI L, Merlotti D, Figura N, Mingiano C, et al
    INFECTION BY CAGA POSITIVE HELICOBACTER PYLORI STRAINS AND BONE FRAGILITY: A PROSPECTIVE COHORT STUDY.
    J Bone Miner Res. 2020 Aug 13. doi: 10.1002/jbmr.4162.
    PubMed     Abstract available


  138. NEVOLA KT, Kiel DP, Zullo AR, Weiss S, et al
    miRNA Mechanisms Underlying the Association of Beta Blocker Use and Bone Mineral Density.
    J Bone Miner Res. 2020 Aug 12. doi: 10.1002/jbmr.4160.
    PubMed     Abstract available


  139. KOLANU N, Silverstone EJ, Ho BH, Pham H, et al
    Clinical Utility of Computer-aided Diagnosis of Vertebral Fractures from Computed Tomography (CT) Images.
    J Bone Miner Res. 2020 Aug 4. doi: 10.1002/jbmr.4146.
    PubMed     Abstract available


  140. ZHAO X, Ning L, Xie Z, Jie Z, et al
    The Novel p38 Inhibitor, Pamapimod, Inhibits Osteoclastogenesis and Counteracts Estrogen-Dependent Bone Loss in Mice.
    J Bone Miner Res. 2020;35:1618-1619.
    PubMed    


    July 2020
  141. SKARP S, Xia JH, Zhang Q, Loija M, et al
    Exome sequencing reveals a phenotype modifying variant in ZNF528 in primary osteoporosis with a COL1A2 deletion.
    J Bone Miner Res. 2020 Jul 28. doi: 10.1002/jbmr.4145.
    PubMed     Abstract available


  142. LI G, Compston JE, Leslie WD, Thabane L, et al
    Relationship between obesity and risk of major osteoporotic fracture in postmenopausal women: taking frailty into consideration.
    J Bone Miner Res. 2020 Jul 27. doi: 10.1002/jbmr.4139.
    PubMed     Abstract available


  143. NAPOLI N, Conte C, Eastell R, Ewing SK, et al
    Bone turnover markers do not predict fracture risk in type 2 diabetes.
    J Bone Miner Res. 2020 Jul 27. doi: 10.1002/jbmr.4140.
    PubMed     Abstract available


  144. COMPSTON JE, Drake MT
    Defining very high fracture risk: Is FRAX fit for purpose?
    J Bone Miner Res. 2020 Jul 22. doi: 10.1002/jbmr.4134.
    PubMed    


  145. HAYES KN, Giannakeas V, Wong AKO
    Bisphosphonate use is protective of radiographic knee osteoarthritis progression among those with low disease severity and being non-overweight: data from the Osteoarthritis Initiative.
    J Bone Miner Res. 2020 Jul 14. doi: 10.1002/jbmr.4133.
    PubMed     Abstract available


  146. HARRISON KD, Hiebert BD, Panahifar A, Andronowski JM, et al
    Cortical Bone Porosity in Rabbit Models of Osteoporosis.
    J Bone Miner Res. 2020 Jul 2. doi: 10.1002/jbmr.4124.
    PubMed     Abstract available


    June 2020
  147. NABWIRE F, Prentice A, Hamill MM, Fowler MG, et al
    Changes in bone mineral density during and after lactation in Ugandan women with HIV on tenofovir-based antiretroviral therapy.
    J Bone Miner Res. 2020 Jun 23. doi: 10.1002/jbmr.4121.
    PubMed     Abstract available


  148. BHATTACHARYYA T
    Osteoporotic Fractures in the Time of COVID-19.
    J Bone Miner Res. 2020 Jun 21. doi: 10.1002/jbmr.4113.
    PubMed    


  149. WONG RH, Zaw JJT, Xian CJ, Howe PR, et al
    Regular supplementation with resveratrol improves bone mineral density in postmenopausal women: a randomised, placebo-controlled trial.
    J Bone Miner Res. 2020 Jun 21. doi: 10.1002/jbmr.4115.
    PubMed     Abstract available


  150. CHEUNG AS, Hoermann R, Ghasem-Zadeh A, Tinson AJ, et al
    Differing effects of zoledronic acid on bone microarchitecture and bone mineral density in men receiving androgen deprivation therapy: a randomised controlled trial.
    J Bone Miner Res. 2020 Jun 16. doi: 10.1002/jbmr.4106.
    PubMed     Abstract available


  151. JOHANSSON L, Sundh D, Magnusson P, Rukmangatharajan K, et al
    Grade 1 vertebral fractures identified by densitometric lateral spine imaging predict incident major osteoporotic fracture independently of clinical risk factors and bone mineral density in older women.
    J Bone Miner Res. 2020 Jun 15. doi: 10.1002/jbmr.4108.
    PubMed     Abstract available


  152. SING CW, Kiel DP, Hubbard RB, Lau WC, et al
    Nitrogen-Containing Bisphosphonates Are Associated With Reduced Risk of Pneumonia in Patients With Hip Fracture.
    J Bone Miner Res. 2020 Jun 2. doi: 10.1002/jbmr.4030.
    PubMed     Abstract available


  153. HOFBAUER LC, Rivadeneira F, Westendorf JJ, Civitelli R, et al
    Scientific Editing in the COVID-19 Era-Personal Vignettes from the JBMR Editors.
    J Bone Miner Res. 2020;35:1005-1008.
    PubMed    


    May 2020
  154. WAQAS K, Chen J, Koromani F, Trajanoska K, et al
    Skin autofluorescence, a non-invasive biomarker for advanced glycation end-products, is associated with prevalent vertebral and major osteoporotic fractures: The Rotterdam Study.
    J Bone Miner Res. 2020 May 28. doi: 10.1002/jbmr.4096.
    PubMed     Abstract available


  155. SOLLING AS, Harslof T, Langdahl B
    Treatment with zoledronate subsequent to denosumab in osteoporosis: a randomized trial.
    J Bone Miner Res. 2020 May 27. doi: 10.1002/jbmr.4098.
    PubMed     Abstract available


  156. MAKITIE RE, Hackl M, Weigl M, Frischer A, et al
    Unique, gender-dependent serum microRNA profile in PLS3 gene-related osteoporosis.
    J Bone Miner Res. 2020 May 26. doi: 10.1002/jbmr.4097.
    PubMed     Abstract available


  157. LADEMANN F, Weidner H, Tsourdi E, Kumar R, et al
    Disruption of BMP signaling prevents hyperthyroidism-induced bone loss in male mice.
    J Bone Miner Res. 2020 May 26. doi: 10.1002/jbmr.4092.
    PubMed     Abstract available


  158. COSMAN F, Lewiecki EM, Ebeling PR, Hesse E, et al
    T-Score as an Indicator of Fracture Risk During Treatment With Romosozumab or Alendronate in the ARCH Trial.
    J Bone Miner Res. 2020 May 22. doi: 10.1002/jbmr.3996.
    PubMed     Abstract available


  159. YU EW, Tsourdi E, Clarke BL, Bauer DC, et al
    Osteoporosis Management in the Era of COVID-19.
    J Bone Miner Res. 2020 May 14. doi: 10.1002/jbmr.4049.
    PubMed     Abstract available


  160. SAAG KG, Curtis JR, Reid IR
    Reply to Serious Adverse Events With Romosozumab Use in Japanese Patients: Need for Clear Formulation of Contraindications Worldwide.
    J Bone Miner Res. 2020;35:996-997.
    PubMed    


    April 2020
  161. HURTADO I, Garcia-Sempere A, Peiro S, Rodriguez-Bernal C, et al
    Trends and geographical variability in osteoporosis treatment after hip fracture: a multilevel analysis of 30,965 patients in the region of Valencia, Spain.
    J Bone Miner Res. 2020 Apr 16. doi: 10.1002/jbmr.4028.
    PubMed     Abstract available


  162. WANG Q, Chen D, Jin H, Ye Z, et al
    Hymenialdisine: a marine natural product acts on both osteoblasts and osteoclasts and prevents estrogen-dependent bone loss in mice.
    J Bone Miner Res. 2020 Apr 14. doi: 10.1002/jbmr.4025.
    PubMed     Abstract available


    March 2020
  163. LI H, Wallin M, Barregard L, Sallsten G, et al
    Smoking-induced risk of osteoporosis is partly mediated by cadmium from tobacco smoke: The MrOS Sweden Study.
    J Bone Miner Res. 2020 Mar 19. doi: 10.1002/jbmr.4014.
    PubMed     Abstract available


  164. PACCOU J, Martignene N, Lespessailles E, Babykina E, et al
    Gastric bypass but not sleeve gastrectomy increases risk of major osteoporotic fracture: French population-based cohort study.
    J Bone Miner Res. 2020 Mar 18. doi: 10.1002/jbmr.4012.
    PubMed    


  165. HARDING AT, Weeks BK, Lambert C, Watson SL, et al
    A comparison of bone-targeted exercise strategies to reduce fracture risk in middle-aged and older men with osteopenia and osteoporosis: LIFTMOR-M semi-randomized controlled trial.
    J Bone Miner Res. 2020 Mar 16. doi: 10.1002/jbmr.4008.
    PubMed     Abstract available


  166. ZHENG J, Brion MJ, Kemp JP, Warrington NM, et al
    The Effect of Plasma Lipids and Lipid-Lowering Interventions on Bone Mineral Density: A Mendelian Randomization Study.
    J Bone Miner Res. 2020 Mar 12. doi: 10.1002/jbmr.3989.
    PubMed     Abstract available


  167. SHAO L, Wu XD
    The Efficacy of Denosumab for Prevention of Early Periprosthetic Bone Loss After Cementless Total Hip Arthroplasty.
    J Bone Miner Res. 2020 Mar 12. doi: 10.1002/jbmr.3983.
    PubMed    


  168. RECKER R, Dempster D, Langdahl B, Giezek H, et al
    Effects of Odanacatib on Bone Structure and Quality in Postmenopausal Women with Osteoporosis: 5-year Data from the Phase 3 Long-Term Odanacatib Fracture Trial (LOFT) and its Extension.
    J Bone Miner Res. 2020 Mar 2. doi: 10.1002/jbmr.3994.
    PubMed     Abstract available


  169. NYSTROM A, Hailer NP, Mallmin H
    In Reply to the Letter to the Editor: The Efficacy of Denosumab for Prevention of Early Periprosthetic Bone Loss After Cementless Total Hip Arthroplasty.
    J Bone Miner Res. 2020 Mar 2. doi: 10.1002/jbmr.3981.
    PubMed    


    February 2020
  170. AXELSSON KF, Johansson H, Lundh D, Moller M, et al
    Association Between Recurrent Fracture Risk and Implementation of Fracture Liaison Services in four Swedish hospitals A Cohort Study.
    J Bone Miner Res. 2020 Feb 25. doi: 10.1002/jbmr.3990.
    PubMed     Abstract available


  171. ZHOU J, Xue Y
    Depression and Bone Mineral Density.
    J Bone Miner Res. 2020 Feb 14. doi: 10.1002/jbmr.3965.
    PubMed    


  172. OCHS-BALCOM HM, Bea JW, Hovey KM, Cauley JA, et al
    Reply to Depression and Bone Mineral Density.
    J Bone Miner Res. 2020 Feb 14. doi: 10.1002/jbmr.3968.
    PubMed    


  173. CHANDRA A, Lagnado AB, Farr JN, Monroe DG, et al
    Targeted reduction of senescent cell burden alleviates focal radiotherapy-related bone loss.
    J Bone Miner Res. 2020 Feb 5. doi: 10.1002/jbmr.3978.
    PubMed     Abstract available


  174. BLACK DM, Sellmeyer DE
    Now That You Can Get What You Want, Can You Keep What You Need?
    J Bone Miner Res. 2020;35:217-218.
    PubMed    


    January 2020
  175. ROLVIEN T, Milovanovic P, Schmidt FN, von Kroge S, et al
    Long-term immobilization in elderly females causes a specific pattern of cortical bone and osteocyte deterioration different from postmenopausal osteoporosis.
    J Bone Miner Res. 2020 Jan 30. doi: 10.1002/jbmr.3970.
    PubMed     Abstract available


  176. LI G, Leslie WD, Kovacs CS, Prior J, et al
    Combining frailty and trabecular bone score did not improve predictive accuracy in risk of major osteoporotic fractures.
    J Bone Miner Res. 2020 Jan 29. doi: 10.1002/jbmr.3971.
    PubMed     Abstract available


  177. CLINE-SMITH A, Axelbaum A, Shashkova E, Chakraborty M, et al
    Ovariectomy activates chronic low-grade inflammation mediated by memory T-cells which promotes osteoporosis in mice.
    J Bone Miner Res. 2020 Jan 29. doi: 10.1002/jbmr.3966.
    PubMed     Abstract available


  178. MAKITIE RE, Kampe A, Costantini A, Alm JJ, et al
    Biomarkers in WNT1 and PLS3 osteoporosis: Altered concentrations of DKK1 and FGF23.
    J Bone Miner Res. 2020 Jan 22. doi: 10.1002/jbmr.3959.
    PubMed     Abstract available


  179. ALARKAWI D, Ali MS, Bliuc D, Pallares N, et al
    Oral bisphosphonate use and all-cause mortality in patients with moderate-severe (grade 3B-5D) chronic kidney disease: a population-based cohort study.
    J Bone Miner Res. 2020 Jan 22. doi: 10.1002/jbmr.3961.
    PubMed     Abstract available


  180. ZHOU YM, Yang YY, Jing YX, Yuan TJ, et al
    BMP9 reduces bone loss in ovariectomized mice by dual regulation of bone remodeling.
    J Bone Miner Res. 2020 Jan 8. doi: 10.1002/jbmr.3957.
    PubMed     Abstract available


  181. TOTH E, Banefelt J, Akesson K, Spangeus A, et al
    History of Previous Fracture and Imminent Fracture Risk in Swedish Women Aged 55-90 Years Presenting with a Fragility Fracture.
    J Bone Miner Res. 2020 Jan 8. doi: 10.1002/jbmr.3953.
    PubMed     Abstract available


  182. LORENTZON M
    The Importance and Possible Clinical Impact of Measuring Trabecular and Cortical Bone Microstructure to Improve Fracture Risk Prediction.
    J Bone Miner Res. 2020 Jan 7. doi: 10.1002/jbmr.3940.
    PubMed    


  183. DUCKWORTH AD, McQueen MM, Tuck CE, Tobias JH, et al
    Response to: Effects of Alendronic Acid on Fracture Healing.
    J Bone Miner Res. 2020;35:215-216.
    PubMed    


    December 2019
  184. SCHEPPER JD, Collins F, Rios-Arce ND, Kang HJ, et al
    Involvement of the gut microbiota and barrier function in glucocorticoid induced osteoporosis.
    J Bone Miner Res. 2019 Dec 30. doi: 10.1002/jbmr.3947.
    PubMed     Abstract available


  185. KAISER J, Allaire B, Fein PM, Lu D, et al
    Heterogeneity and Spatial Distribution of Intravertebral Trabecular Bone Mineral Density in the Lumbar Spine is Associated with Prevalent Vertebral Fracture.
    J Bone Miner Res. 2019 Dec 30. doi: 10.1002/jbmr.3946.
    PubMed     Abstract available


  186. XUE Y, Yang J, Luo J, Ren L, et al
    Disorder of iron metabolism inhibits the recovery of unloading-induced bone loss in hypomagnetic field.
    J Bone Miner Res. 2019 Dec 27. doi: 10.1002/jbmr.3949.
    PubMed     Abstract available


  187. KELLER-BARUCH J, Forgetta V, Manousaki D, Zhou S, et al
    Genetically decreased circulating vascular endothelial growth factor and osteoporosis outcomes: A Mendelian randomization study.
    J Bone Miner Res. 2019 Dec 10. doi: 10.1002/jbmr.3937.
    PubMed     Abstract available


  188. CHAPURLAT R, Bui M, Sornay-Rendu E, Zebaze R, et al
    Deterioration of Cortical and Trabecular Microstructure Identifies Women With Osteopenia or Normal Bone Mineral Density at Imminent and Long-Term Risk for Fragility Fracture: A Prospective Study.
    J Bone Miner Res. 2019 Dec 10. doi: 10.1002/jbmr.3924.
    PubMed     Abstract available


  189. ARMAMENTO-VILLAREAL R, Aguirre L, Waters DL, Napoli N, et al
    Effect of Aerobic or Resistance Exercise, or Both, on Bone Mineral Density and Bone Metabolism in Obese Older Adults While Dieting: A Randomized Controlled Trial.
    J Bone Miner Res. 2019 Dec 4. doi: 10.1002/jbmr.3905.
    PubMed     Abstract available


  190. ALONSO N, Larraz-Prieto B, Berg K, Lambert Z, et al
    Loss-of-function mutations in the ALPL gene presenting with adult onset osteoporosis and low serum concentrations of total alkaline phosphatase.
    J Bone Miner Res. 2019 Dec 2. doi: 10.1002/jbmr.3928.
    PubMed     Abstract available


    November 2019
  191. MA J, Siminoski K, Wang P, Alos N, et al
    The Accuracy of Prevalent Vertebral Fracture Detection in Children Using Targeted Case Finding Approaches.
    J Bone Miner Res. 2019 Nov 19. doi: 10.1002/jbmr.3922.
    PubMed     Abstract available


  192. SUN H, Qiao W, Cui M, Yang C, et al
    The Polycomb Protein Bmi1 Plays a Crucial Role in the Prevention of 1,25(OH)2 D Deficiency-induced Bone Loss.
    J Bone Miner Res. 2019 Nov 14. doi: 10.1002/jbmr.3921.
    PubMed     Abstract available


  193. ADAMI G, Jaleel A, Curtis JR, Delzell E, et al
    Temporal trends and factors associated with bisphosphonate discontinuation and restart.
    J Bone Miner Res. 2019 Nov 12. doi: 10.1002/jbmr.3915.
    PubMed     Abstract available


  194. PRIETO-ALHAMBRA D, Turkiewicz A, Reyes C, Timpka S, et al
    Smoking and alcohol intake but not muscle strength in young men increase fracture risk at middle age: a cohort study linked to the Swedish National Patient Registry.
    J Bone Miner Res. 2019 Nov 12. doi: 10.1002/jbmr.3917.
    PubMed     Abstract available


  195. OGUNWALE AN, Colon-Emeric CS, Sloane R, Adler RA, et al
    Acetylcholinesterase inhibitors are associated with reduced fracture risk among older Veterans with dementia.
    J Bone Miner Res. 2019 Nov 11. doi: 10.1002/jbmr.3916.
    PubMed     Abstract available


  196. OCHS-BALCOM HM, Hovey KM, Andrews C, Cauley JA, et al
    Short Sleep Is Associated With Low Bone Mineral Density and Osteoporosis in the Women's Health Initiative.
    J Bone Miner Res. 2019 Nov 6. doi: 10.1002/jbmr.3879.
    PubMed     Abstract available


  197. CHU L, Liu X, He Z, Han X, et al
    Articular cartilage degradation and aberrant subchondral bone remodeling in patients with osteoarthritis and osteoporosis.
    J Bone Miner Res. 2019 Nov 6. doi: 10.1002/jbmr.3909.
    PubMed     Abstract available


  198. JIN H, Ma X, Liu Y, Yin X, et al
    Back Pain-Inducing Test, a novel and sensitive screening test for painful osteoporotic vertebral fractures: A prospective clinical study.
    J Bone Miner Res. 2019 Nov 6. doi: 10.1002/jbmr.3912.
    PubMed     Abstract available


  199. OHEIM R, Zimmerman K, Maulding ND, Sturznickel J, et al
    Human Heterozygous ENPP1 Deficiency Is Associated With Early Onset Osteoporosis, a Phenotype Recapitulated in a Mouse Model of Enpp1 Deficiency.
    J Bone Miner Res. 2019 Nov 5. doi: 10.1002/jbmr.3911.
    PubMed     Abstract available


  200. WONG AK, Chandrakumar A, Whyte R, Reitsma S, et al
    Bone Marrow and Muscle Fat Infiltration are Correlated Among Postmenopausal Women with Osteoporosis: the AMBERS Cohort Study.
    J Bone Miner Res. 2019 Nov 1. doi: 10.1002/jbmr.3910.
    PubMed     Abstract available


  201. WANG W, Wang H, Zhou X, Li X, et al
    Lymphatic Endothelial Cells Produce M-CSF, Causing Massive Bone Loss in Mice.
    J Bone Miner Res. 2019;34:2162.
    PubMed    


    October 2019
  202. WOODS GN, Ewing SK, Sigurdsson S, Kado DM, et al
    Greater Bone Marrow Adiposity Predicts Bone Loss in Older Women.
    J Bone Miner Res. 2019 Oct 16. doi: 10.1002/jbmr.3895.
    PubMed     Abstract available


  203. SUN M, Hu L, Wang S, Huang T, et al
    Circulating MicroRNA-19b Identified from Osteoporotic Vertebral Compression Fracture Patients Increases Bone Formation.
    J Bone Miner Res. 2019 Oct 15. doi: 10.1002/jbmr.3892.
    PubMed     Abstract available


  204. PINEDA-MONCUSI M, Garcia-Giralt N, Diez-Perez A, Servitja S, et al
    Increased Fracture Risk in Women Treated with Aromatase Inhibitors versus Tamoxifen: Beneficial Effect of Bisphosphonates.
    J Bone Miner Res. 2019 Oct 9. doi: 10.1002/jbmr.3886.
    PubMed     Abstract available


  205. NYSTROM A, Kiritopoulos D, Ullmark G, Sorensen J, et al
    Denosumab Prevents Early Periprosthetic Bone Loss after Uncemented Total Hip Arthroplasty: Results from a Randomized Placebo-Controlled Clinical Trial.
    J Bone Miner Res. 2019 Oct 7. doi: 10.1002/jbmr.3883.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: